Syntegra Private Wealth Group LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,584 shares of the healthcare conglomerate's stock after selling 1,149 shares during the quarter. Syntegra Private Wealth Group LLC's holdings in UnitedHealth Group were worth $830,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $26,000. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the period. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth about $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the 4th quarter worth about $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter worth about $42,000. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
NYSE:UNH traded up $5.59 during trading hours on Friday, hitting $250.26. 7,705,779 shares of the company were exchanged, compared to its average volume of 12,086,206. The stock has a market capitalization of $227.02 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 1.59 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company's 50 day moving average price is $292.78 and its 200-day moving average price is $408.71.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the firm posted $6.80 EPS. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.5%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.
Analysts Set New Price Targets
Several research firms recently commented on UNH. Barclays reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Morgan Stanley cut their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday. JPMorgan Chase & Co. cut their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday. Finally, Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group has an average rating of "Hold" and a consensus target price of $366.52.
Read Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.